Kazuki Sekitani
Director/Board Member at EPS HOLDINGS, INC.
Kazuki Sekitani active positions
| Companies | Position | Start | End |
|---|---|---|---|
| EPS HOLDINGS, INC. | Director/Board Member | 31/03/2011 | - |
| Human Resources Officer | 20/12/2018 | - | |
| Public Communications Contact | 20/12/2018 | - | |
| Corporate Officer/Principal | 31/03/2011 | 20/12/2018 | |
| GNI GROUP LTD. | Director/Board Member | 29/03/2023 | - |
| Independent Dir/Board Member | 29/03/2023 | - |
Career history of Kazuki Sekitani
Former positions of Kazuki Sekitani
| Companies | Position | Start | End |
|---|---|---|---|
| KAKEN PHARMACEUTICAL CO., LTD. | Director/Board Member | 31/05/2013 | - |
EPS Global Research, Inc.
 EPS Global Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of EPS Holdings, Inc., EPS Global Research, Inc. operates clinical trials. | Director/Board Member | 31/05/2012 | - |
Training of Kazuki Sekitani
| University of Tokyo | Undergraduate Degree |
Statistics
International
| Japan | 5 |
| United States | 2 |
Operational
| Director/Board Member | 4 |
| Human Resources Officer | 1 |
| Public Communications Contact | 1 |
Sectoral
| Health Technology | 4 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| KAKEN PHARMACEUTICAL CO., LTD. | Health Technology |
| GNI GROUP LTD. | Health Technology |
| Private companies | 2 |
|---|---|
EPS Holdings, Inc.
 EPS Holdings, Inc. BiotechnologyHealth Technology EPS Holdings, Inc. engages in the drug development business. It operates through the following segments: Contract Research Organization (CRO), Site Management Organization (SMO), Contract Sales Organization (CSO), Global Research, Ekishin, and Others. The CRO segment offers clinical trials, data management, and statistical analysis. The SMO segment enters into contracts with medical institutions to conduct clinical trials. The CSO segment provides drug information and awareness for medical and pharmaceutical industries. The Global Research segment provides consignment services through its subsidiary for multilateral clinical trials in Asia-Pacific. The Ekishin segment focuses on medical equipment, pharmaceutical and investment related businesses through its Japan and China based subsidiaries. The Others segment provides various services related to management of clinical research from business processing outsource business related to medicine and medical care. The company was founded on May 30, 1991 and is headquartered in Tokyo, Japan. | Health Technology |
EPS Global Research, Inc.
EPS Global Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of EPS Holdings, Inc., EPS Global Research, Inc. operates clinical trials. | Commercial Services |
- Stock Market
- Insiders
- Kazuki Sekitani
- Experience
